ArticleInternational journal of oncology2018

ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.

Yunjie Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.